Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mitry

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|December 2, 1998
Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995A M Benhamiche, C Faivre, A Minello, et al.
Diseases of the Colon and Rectum|April 6, 2001
Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French populationE Mitry, A M Benhamiche, J L Jouve, et al.
Bulletin Du Cancer|November 26, 1999
[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]C Faivre, P Rougier, M Ducreux, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 29, 2002
Effect of age, period of diagnosis and birth cohort on large bowel cancer incidence in a well-defined French population, 1976-1995E Mitry, A-M Benhamiche, C Couillault, et al.
Gut|February 23, 1999
Evidence of improving survival of patients with rectal cancer in france: a population based studyC Finn-Faivre, J Maurel, A M Benhamiche, et al.
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Adjuvant chemotherapy for colon adenocarcinoma in the county of Côte-d'Or]J L Jouve, E Mitry, J M Phelip, et al.
Pain|May 22, 2009
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment studyN Attal, D Bouhassira, M Gautron, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Improvement in survival of metastatic colorectal cancer: are the benefits of clinical trials reproduced in population-based studies?E Mitry, F Rollot, V Jooste, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumoursT Aparicio, M Ducreux, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trialsE Mitry, J-Y Douillard, E Van Cutsem, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|December 2, 1998
Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995A M Benhamiche, C Faivre, A Minello, et al.
Diseases of the Colon and Rectum|April 6, 2001
Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French populationE Mitry, A M Benhamiche, J L Jouve, et al.
Bulletin Du Cancer|November 26, 1999
[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]C Faivre, P Rougier, M Ducreux, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 29, 2002
Effect of age, period of diagnosis and birth cohort on large bowel cancer incidence in a well-defined French population, 1976-1995E Mitry, A-M Benhamiche, C Couillault, et al.
Gut|February 23, 1999
Evidence of improving survival of patients with rectal cancer in france: a population based studyC Finn-Faivre, J Maurel, A M Benhamiche, et al.
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Adjuvant chemotherapy for colon adenocarcinoma in the county of Côte-d'Or]J L Jouve, E Mitry, J M Phelip, et al.
Pain|May 22, 2009
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment studyN Attal, D Bouhassira, M Gautron, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Improvement in survival of metastatic colorectal cancer: are the benefits of clinical trials reproduced in population-based studies?E Mitry, F Rollot, V Jooste, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumoursT Aparicio, M Ducreux, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trialsE Mitry, J-Y Douillard, E Van Cutsem, et al.
Pageof 6